Durin Technologies, Inc.

Amendment
CIK: 0001797306·Biotechnology·NEW JERSEY·Filed: Jan 9, 2023
Total Offering

$5,499,900

Amount Sold

$4,554,000

Investors

2

First Sale

Mar 16, 2021

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Benjamin A. Belinka, Jr.
Related Person
Robert Nagele
Related Person
Rene Chaze
Related Person

Company

Durin Life Sciences, Inc.

107 GILBRETH PARKWAY

MULLICA HILL, NJ, 08062

732-371-2694

SEC Filing

0001797306-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Durin Technologies, Inc. Form D Filing — $5,499,900 | FilingFlow